BSX Stock Analysis: Buy, Sell, or Hold?
BSX - Boston Scientific Corp.
$48.50
-1.37 (-2.74%)
âŧ
5d:
-6.76%
30d:
+5.29%
90d:
-3.89%
WAIT
LOW Confidence
Analysis Updated: Aug 26, 2026 12:00 AM ET
Earnings: Jul 29, 2026
0d
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Aug 20, 2026 at $49.37 · last confirmed Aug 25, 2026
Strength: 9.5/10
Get Alerted When BSX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: BSX is fairly priced but lacks strong directional signals. At -7.0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: BSX is fairly priced but lacks strong directional signals. At -7.0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$75.42
Based on 4.0% avg growth
INTRINSIC VALUE TODAY
$46.83
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 18.1x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BSX is currently trading at $48.49, which is considered fair relative to its 30-day fair value range of $45.36 to $51.03. From a valuation perspective, the stock is trading at a discount (Forward PE: 14.5) compared to its historical average (18.1). Remarkably, the market is currently pricing in an annual earnings decline of 7.0% over the next few years. This pessimistic expectation contrasts with the company's recent 15.1% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, BSX is in a strong downtrend. Immediate support is located at $46.90, while resistance sits at $52.99.
Market Sentiment: BSX scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $62.69 (+25.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BSX is in a strong downtrend. Immediate support is located at $46.90, while resistance sits at $52.99.
Market Sentiment: BSX scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $62.69 (+25.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$45.36 -
$51.03
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
Protect Your Profits
Holding BSX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (20/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 25.7% below Wall St target ($62.69)
- WARNING: Composite score 46/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$45.36 -
$51.03
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$46.90
Resistance Level
$52.99
Current Trend
Strong Downtrend
Technical data as of
Aug 26, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.52
Wall Street Target
$62.69
(+25.7%)
Revenue Growth (YoY)
7.5%
Earnings Growth (YoY)
15.1%
Profit Margin
17.5%
Valuation Discount vs History
-7.0% cheaper
PE vs Historical
14.5 vs 18.1
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-7.0%
(market-implied from PE analysis)
1-Year Target
$46.37
(-7%)
2-Year Target
$43.12
(-14%)
3-Year Target
$40.11
(-20%)
3-Yr Target (if PE normalizes)
(PE: 15â18)
$49.98
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.1, Growth: 3.9%)
$77.27
(+55%)
Base:
(SPY PE: 14.5, Growth: 3.9%)
$55.97
(+12%)
Bear:
(PE: 12.3, Growth: 3.9%)
$47.57
(-5%)
đ
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (20x PE), but valuation improves significantly next year (15x PE) as earnings recover.
Trailing PE: 20.42 | Current EPS (TTM): $2.40
Bull Case
$77.12
(+55%)
Analyst growth 43.1%, PE expands to 22.5
Base Case
$70.11
(+41%)
Market implied 43.1%, PE stable at 20.4
Bear Case
$33.33
(-33%)
Severe decline -20.0%, PE contracts to 17.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
đĄ
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 14.5 to 18.1
Stabilization Target:
$62.14
(+24.6%)
PE Expansion Potential:
+24.6%
Share & Embed Analysis
Last updated: August 26, 2026 3:38 PM ET
Data refreshes hourly during market hours. Next update: 4:38 PM
Data refreshes hourly during market hours. Next update: 4:38 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BSX showing a specific setup today?
Insider Activity (6 Months)
1
Buys
1
Sells
0
Net
NEUTRAL
Recent Transactions
Ro Khanna
BUY
2026-03-30
Ro Khanna
SELL
2026-03-23
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$383 | 61 BUY |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$172 | 57 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 43 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 49 HOLD |
|
GEHC
GE HealthCare TechnologiâĻ |
STRONG BUY
21 analysts |
$83 | 37 SELL |
Advanced BSX Option Strategies
Professional options setups generated by AI based on today's BSX price and gamma walls.
